It is postulated that with the progression of acute histologic chorioamnionitis, there is a decrease in the level of the intact form of insulin-like growth factor binding protein 1, ultimately affecting IGF-1 bioavailability (15, 16). This evidence concerns the gene IGFBPL1 and chorioamnionitis.